New Pill Doubles Survival for Pancreatic Cancer Patients

An experimental once-daily pill nearly doubled survival time for patients with advanced pancreatic cancer, offering hope for one of the deadliest forms of the disease.

The breakthrough targets a mutation present in over 90% of pancreatic tumors that scientists have struggled to treat for four decades.